Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 7 January 1983:
Vol. 219. no. 4580, pp. 75 - 77
DOI: 10.1126/science.6849120

Articles

Science, Vol 219, Issue 4580, 75-77
Copyright © 1983 by American Association for the Advancement of Science


articles

Effects of tyrosine administration on serum biopterin in normal controls and patients with Parkinson's disease

T Yamaguchi, T Nagatsu, T Sugimoto, S Matsuura, T Kondo, R Iizuka, and H Narabayashi

After administration of tyrosine, total concentration of biopterin, the cofactor for tyrosine hydroxylase, was increased in the striatum, adrenal glands, and serum of rats, and in the serum of humans. Serum biopterin is lower in patients with Parkinson's disease than in normal controls. After oral administration of tyrosine, the increase in serum biopterin concentration was smaller in patients with Parkinson's disease (less than twofold) than in healthy controls (three-to sevenfold). These results suggest that tyrosine may have a regulatory role in biopterin biosynthesis and that patients with Parkinson's disease may have some abnormality in the regulation of biopterin biosynthesis.





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)